Moors & Cabot, Inc. Moderna, Inc. Transaction History

Moors & Cabot, Inc.

$1.81 Billion
Q1 2024

A detailed history of Moors & Cabot, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 45,969 shares of MRNA stock, worth $5.38 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

45,969

Previous 40,050 14.78%

Holding current value

$5.38 Million

Previous $3.98 Million 23.0%

% of portfolio

0.27%

Previous 0.25%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$85.37 - $115.44 $505,305 - $683,289	5,919 Added 14.78%	45,969 $4.9 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $844,476 - $1.27 Million	12,149 Added 43.54%	40,050 $3.98 Million
Q3 2023 Nov 07, 2023	SELL	$96.41 - $126.61 $675,544 - $887,156	-7,007 Reduced 20.07%	27,901 $2.88 Million
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $134,971 - $182,843	-1,139 Reduced 3.16%	34,908 $4.24 Million
Q1 2023 May 04, 2023	SELL	$135.66 - $197.02 $36,763 - $53,392	-271 Reduced 0.75%	36,047 $5.54 Million

Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $39,065 - $69,313	-330 Reduced 0.9%	36,318 $6.52 Million
Q4 2022 Feb 06, 2023	SELL	$118.38 - $210.04 $20,716 - $36,757	-175 Reduced 0.48%	36,648 $6.58 Million
Q3 2022 Nov 07, 2022	SELL	$118.07 - $194.18 $37,073 - $60,972	-314 Reduced 0.85%	36,823 $4.35 Million
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $39,121 - $58,981	334 Added 0.91%	37,137 $5.31 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $154,281 - $286,761	-1,220 Reduced 3.21%	36,803 $6.34 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $241,627 - $394,305	-1,070 Reduced 2.74%	38,023 $9.66 Million
Q3 2021 Dec 08, 2021	BUY	$221.9 - $484.47 $3.13 Million - $6.83 Million	14,093 Added 56.37%	39,093 $15 Million
Q3 2021 Nov 05, 2021	SELL	$221.9 - $484.47 $4.62 Million - $10.1 Million	-20,824 Reduced 45.44%	25,000 $29,000
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $53,003 - $95,871	-408 Reduced 0.88%	45,824 $10.8 Million
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $59,612 - $101,545	546 Added 1.2%	46,232 $6.05 Million
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $20,708 - $53,505	315 Added 0.69%	45,686 $4.77 Million
Q3 2020 Nov 09, 2020	SELL	$54.34 - $94.85 $207,035 - $361,378	-3,810 Reduced 7.75%	45,371 $3.21 Million
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $398,705 - $1.08 Million	-13,438 Reduced 21.46%	49,181 $3.15 Million
Q1 2020 May 12, 2020	BUY	$17.78 - $31.58 $231,140 - $410,540	13,000 Added 26.2%	62,619 $1.88 Million
Q4 2019 Jan 28, 2020	BUY	$13.93 - $21.28 $137,907 - $210,672	9,900 Added 24.93%	49,619 $980,000
Q3 2019 Oct 22, 2019	BUY	$12.26 - $18.07 $100,532 - $148,174	8,200 Added 26.02%	39,719 $632,000
Q2 2019 Jul 18, 2019	BUY	$13.7 - $28.34 $431,810 - $893,248	31,519 New	31,519 $456,000

Others Institutions Holding MRNA

# of Institutions

1,037

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account